Goldman Sachs’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Sell |
326,233
-88,788
| -21% | -$331K | ﹤0.01% | 3719 |
|
|
2025
Q1 | $1.15M | Buy |
415,021
+71,971
| +21% | +$199K | ﹤0.01% | 3721 |
|
|
2024
Q4 | $1.9M | Sell |
343,050
-75,817
| -18% | -$420K | ﹤0.01% | 3511 |
|
|
2024
Q3 | $3.49M | Sell |
418,867
-279,847
| -40% | -$2.33M | ﹤0.01% | 3000 |
|
|
2024
Q2 | $4.76M | Buy |
698,714
+491,728
| +238% | +$3.35M | ﹤0.01% | 2643 |
|
|
2024
Q1 | $1.36M | Buy |
206,986
+121,395
| +142% | +$796K | ﹤0.01% | 3434 |
|
|
2023
Q4 | $555K | Sell |
85,591
-173,705
| -67% | -$1.13M | ﹤0.01% | 3896 |
|
|
2023
Q3 | $1.3M | Buy |
259,296
+201,514
| +349% | +$1.01M | ﹤0.01% | 3362 |
|
|
2023
Q2 | $506K | Sell |
57,782
-31,522
| -35% | -$276K | ﹤0.01% | 3976 |
|
|
2023
Q1 | $1.06M | Buy |
89,304
+78,474
| +725% | +$929K | ﹤0.01% | 3624 |
|
|
2022
Q4 | $110K | Sell |
10,830
-1,086
| -9% | -$11.1K | ﹤0.01% | 4652 |
|
|
2022
Q3 | $70K | Sell |
11,916
-4,672
| -28% | -$27.4K | ﹤0.01% | 4993 |
|
|
2022
Q2 | $41K | Buy |
16,588
+161
| +1% | +$398 | ﹤0.01% | 5319 |
|
|
2022
Q1 | $49K | Buy |
16,427
+1,219
| +8% | +$3.64K | ﹤0.01% | 5475 |
|
|
2021
Q4 | $108K | Buy |
+15,208
| New | +$108K | ﹤0.01% | 5199 |
|